Cognition Therapeutics, Inc. Increase (Decrease) in Other Receivables
Cognition Therapeutics, Inc. (CGTX) reported Increase (Decrease) in Other Receivables of -$467.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherReceivables · last filed 2024-03-26
- Cognition Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2022-12-31 was -$2.00K, a 101.40% decline year-over-year.
- Cognition Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2022-09-30 was $2.00K, a 92.00% decline year-over-year.
- Cognition Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2022-06-30 was $0.00.
- Cognition Therapeutics, Inc. increase (decrease) in other receivables for the quarter ending 2022-03-31 was -$467.00K, a 841.27% decline year-over-year.
- Cognition Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2022 was -$467.00K.
- Cognition Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2021 was -$121.00K.
- Cognition Therapeutics, Inc. increase (decrease) in other receivables for fiscal 2020 was -$904.00K.
| Period end | Increase (Decrease) in Other Receivables 3 month | Increase (Decrease) in Other Receivables 6 month | Increase (Decrease) in Other Receivables 9 month | Increase (Decrease) in Other Receivables 12 month |
|---|---|---|---|---|
| 2022-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $0.00 derived: sum of 2 quarters · filed 2024-03-26 | $0.00 derived: sum of 3 quarters · filed 2024-03-26 | -$467.00K 10-K · filed 2024-03-26 |
| 2022-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.00K derived: sum of 2 quarters · filed 2023-11-02 | -$465.00K 10-Q · filed 2023-11-02 | -$322.00K derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$467.00K 10-Q · filed 2022-08-09 | -$324.00K derived: sum of 3 quarters · filed 2023-03-23 | -$299.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2022-03-31 | -$467.00K 10-Q · filed 2022-05-11 | -$324.00K derived: sum of 2 quarters · filed 2023-03-23 | -$299.00K derived: sum of 3 quarters · filed 2023-03-23 | -$651.00K derived: sum of 4 quarters · filed 2023-03-23 |
| 2021-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $168.00K derived: sum of 2 quarters · filed 2023-03-23 | -$184.00K derived: sum of 3 quarters · filed 2023-03-23 | -$121.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$327.00K derived: sum of 2 quarters · filed 2022-11-14 | -$264.00K 10-Q · filed 2022-11-14 | -$202.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$352.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$289.00K 10-Q · filed 2022-08-09 | -$227.00K derived: sum of 3 quarters · filed 2022-08-09 | |
| 2021-03-31 | $63.00K 10-Q · filed 2022-05-11 | $125.00K derived: sum of 2 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$904.00K 10-K · filed 2022-03-30 | ||
| 2020-09-30 | -$966.00K 10-Q · filed 2021-11-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |